Complement activation in the central nervous system following blood-brain barrier damage in man.
about
Complement in the Homeostatic and Ischemic BrainMolecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?Immune abnormalities in aneurysmal subarachnoid haemorrhage patients: relation to delayed cerebral vasospasmDecay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injuryPathophysiology of septic encephalopathy--an unsolved puzzle.Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human strokeVersatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasisCardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcomeEffects of innate immunity on herpes simplex virus and its ability to kill tumor cells.Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic reviewSpontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysisIntravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study.Complement in neuroprotection and neurodegeneration.The role of the complement system in CNS inflammatory diseases.The immunology of acute stroke.Role of complement in multiorgan failure.Injury site-specific targeting of complement inhibitors for treating stroke.CD59 efficiently protects human NT2-N neurons against complement-mediated damage.Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.Systemic complement activation following human acute ischaemic stroke.Ficolin-1 Levels in Patients Developing Vasospasm and Cerebral Ischemia After Spontaneous Subarachnoid Hemorrhage.Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats.Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months.The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury.Complement activation and its prognostic role in post-cardiac arrest patients.Poststroke delivery of MANF promotes functional recovery in rats.
P2860
Q26796057-E3554590-53B8-4F0B-A75C-FC87AEBD7A01Q26825724-784F21C8-0D74-4F50-807B-87496FA4D156Q28374437-4A6FBA10-B009-4DF6-9EED-6D524CF1456EQ28574989-90688C91-904B-491A-AB62-BB6689C5589BQ33349282-5122DB83-0BA1-4A70-81D1-5220017AF040Q33530136-777CD741-0724-452C-9F70-10EA2846387FQ34471200-151CDFE6-3C57-437A-B666-C70B633CE37FQ34973359-3846AC12-24D5-499F-A77F-94F11DBB8572Q35131235-90308033-F6C8-44D0-BF59-8F3BF71F148EQ35136554-88712799-0F00-414D-ACC9-00F24BE85B0EQ35829491-3F63DF8C-0984-4DA6-97A7-B02EB90BCA67Q35956863-3084D7F0-FA5B-4EE5-ADC1-F5DB8F21338FQ37091310-8C15F688-2798-413D-A9ED-CC26229A365EQ37281552-F608ADF3-6034-4B73-B5C6-E5CF9E6E449AQ37684123-225EEC5A-A5CA-4270-AD9A-AB9E9C647291Q37754532-717B5F31-7C11-4DB5-AC19-A2D29A5F76E4Q38016069-07BB5391-6ACA-42E1-A3FD-71F68F274FD7Q38074156-8361B017-6A9E-41DF-AF63-257C381235B3Q38991032-BAED3762-D77D-4803-86C1-E468F2CFB8B1Q40106379-BC5B5885-E4B9-470A-9DB2-2C4AE1335C72Q40518032-89D95C0A-E725-4322-9576-EA020014B7E1Q41771843-A6625362-686C-4D39-AC87-5BBD01DD1092Q42107475-39639326-A3D6-455F-BE42-498149277A26Q47346589-43E3D2AB-3EA3-40C3-811A-B47B9087C5C0Q48304589-A207211E-70A9-4085-BD6E-4808F2BE5BF0Q48465059-606441BF-87E2-4412-B631-927FEAD1CE02Q48710750-E270F214-01DB-4000-8760-B8A57D54F4E0Q48833059-0482CB8D-B925-4CA9-A47B-87E17BE69473Q50712609-DDA61D62-01B4-45E2-A983-A56DB2BAD3AFQ54984571-BADFBB38-1EF8-4D7A-AF2A-9BE261F97513
P2860
Complement activation in the central nervous system following blood-brain barrier damage in man.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Complement activation in the c ...... d-brain barrier damage in man.
@en
Complement activation in the c ...... d-brain barrier damage in man.
@nl
type
label
Complement activation in the c ...... d-brain barrier damage in man.
@en
Complement activation in the c ...... d-brain barrier damage in man.
@nl
prefLabel
Complement activation in the c ...... d-brain barrier damage in man.
@en
Complement activation in the c ...... d-brain barrier damage in man.
@nl
P2093
P2860
P50
P356
P1433
P1476
Complement activation in the c ...... d-brain barrier damage in man.
@en
P2093
Karjalainen-Lindsberg ML
Wuorimaa T
P2860
P304
P356
10.1002/ANA.410400408
P577
1996-10-01T00:00:00Z